Abstract:Objective:To explore the protective effect of human bone marrow-derived mesenchymal stem cells (MSC) on lipopolysaccharide (LPS) induced acute lung injury (ALI).Methods:This was expermental reseach.Twenty four male SPF BALF/c mice were randomly divided into three groups, control group, ALI group and ALI+ MSC group.LPS (5mg/kg) was instilled into the trachea two days after the model was made.The lung tissue of the mouse was taken, and the pathological changes of the lung injury were observed by HE staining, and the lung injury score was performed.Alveolar lavage fluid (BALF) was collected, leukocytes were counted and classified by Wright-Giemsa staining.The concentration of total protein and inflammatory cytokines Interleukin 1β (IL-1β), Interleukin 6 ( IL-6) and tumor necrosis factor alpha (TNF-α) were determined.Lung tissue wet-to-dry ratio (W/D), RT-PCR detection of caspase-3, keratinocyte growth factor2(KGF-2), surface active protein C( SPC), proliferating cell nuclear antigen (PCNA) mRNA expression were performed.TUNNEL method was used to detect cell apoptosis in the lung.Immunohistochemistry was used to detect PCNA in the lung.Masson method was used to detect the deposition of collagen fibers in the lung; in vivo imaging of small animals traced the colonization of MSC in the lung.Results:Compared with control group, lung injury score (11.75±1.71) scores vs (2.75±0.96) scores, ( P<0.01), total protein concentration in BALF (1 181.80±297.11) mg/L vs (196.81±58.54) mg/L ( P<0.01), and W/D (5.23±0.15 vs 4.36±0.29) significantly increasedin ALI group (All P<0.01). White blood cells (184.00±20.40)×10 4/L vs (45.00±12.09)×10 4/L, neutrophils (152.00±48.50)×10 4/L vs (1.00±0.58)×10 4/L, P<0.01), macrophages (20.00±5.03 vs 2.00±1.15)×10 4/L, ( P<0.01) in BALF were also significantly increased.After MSC intervention, lung injury significantly improved (4.50±1.29) scores, and W/D (4.53±0.15), total protein in BALF (588.27±72.57) mg/L significantly decreased.IL-1β, IL-6 and TNF-α in BALF and plasma were significantly higherin ALI groupthan in healthy control group, but significantly lower in MSC intervention group.KGF-2 mRNA and SPC mRNA were significantly lower in ALI groupthan in control group.KGF-2 mRNA and SPC mRNA were significantly higherin intervention group than in ALI group.Caspase-3 mRNA and PCNA mRNA were significantly higherin intervention group than in control group, and caspase-3 mRNA and PCNA mRNA were significantly lower in intervention groupthan in ALI group ( P<0.01). Pathological examination showed that the deposition and apoptosis of collagen fibers in the lungs of ALI group increased, while those in MSC intervention group decreased.In vivo imaging of small animals indicated that MSC had reached the blood vessels in the lungs at 2 hours.MSC only settled in the lungs, and did not appear in the liver, bones, spleen and other organs. Conclusions:Human bone marrow-derived mesenchymal stem cells improved ALI in mice.

Study of mesenchymal stem cells derived from lung-resident, bone marrow and chorion for treatment of LPS-induced acute lung injury

Comparative Effects of Umbilical Cord- and Menstrual Blood-Derived MSCs in Repairing Acute Lung Injury

Mesenchymal Stem Cells Alleviate LPS-induced Acute Lung Injury by Inhibiting the Proinflammatory Function of Ly6C+ CD8+ T Cells

Lung-Resident Mesenchymal Stem Cells Promote Repair of LPS-Induced Acute Lung Injury via Regulating the Balance of Regulatory T cells and Th17 cells

Immunosuppressive Effect Of Mesenchymal Stem Cells On Lung And Gut Cd8(+) T Cells In Lipopolysaccharide-Induced Acute Lung Injury In Mice

Effects of different concentrations of mesenchymal stem cells treatment on LPS-induced acute respiratory distress syndrome rat model

Human amnion-derived mesenchymal stem cells attenuate acute lung injury in two different acute lung injury mice models

Effects of human bone marrow mesenchymal stem cells on acute lung injury model in mice

Mesenchymal stem cell treatment restores liver macrophages homeostasis to alleviate mouse acute liver injury revealed by single-cell analysis.

Immunomodulation via MyD88-NFκB Signaling Pathway from Human Umbilical Cord-Derived Mesenchymal Stem Cells in Acute Lung Injury

Chicken bone marrow mesenchymal stem cells improve lung and distal organ injury

Treatment of Acute Respiratory Distress Syndrome with Allogeneic Adipose-Derived Mesenchymal Stem Cells: a Randomized, Placebo-Controlled Pilot Study.

Studies on the Effects of Bone Marrow Stem Cells on Mitochondrial Function and the Alleviation of ARDS

MSCs alleviate LPS-induced acute lung injury by inhibiting the proinflammatory function of macrophages in mouse lung organoid–macrophage model

RNA-Sequencing approach for exploring the therapeutic effect of umbilical cord mesenchymal stem/stromal cells on lipopolysaccharide-induced acute lung injury

Human Mesenchymal Stem (Stromal) Cells Promote the Resolution of Acute Lung Injury in Part through Lipoxin A4

Regulative effect of salmenterol on the mesenchymal stem cells reducing the lipopolysaccharide-induced lung injury in mouse model

Marrow-derived mesenchymal stem cells regulate the inflammatory response and repair alveolar type II epithelial cells in acute lung injury of rats

Mesenchymal stem cell-mediated immunomodulation of recruited mononuclear phagocytes during acute lung injury: a high-dimensional analysis study

Intrapleural Delivery of MSCs Attenuates Acute Lung Injury by Paracrine/endocrine Mechanism

Mesenchymal stromal cells ameliorate acute lung injury induced by LPS mainly through stanniocalcin-2 mediating macrophage polarization